Patents
Patents for C07C 211 - Compounds containing amino groups bound to a carbon skeleton (24,007)
12/2003
12/30/2003US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy
12/30/2003US6670052 Having one or more organic compound layers containing charge transporting polyether comprising specified repeating unit between pair of electrodes, at least one of which is transparent or semitransparent
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/25/2003US20030236225 Substituted ethylene diamines for the treatment of infectious diseases; used for mycobacterial infections, including tuberculosis
12/24/2003WO2003106469A1 Tumour-inhibiting platinum (ii) oxalate complexes
12/24/2003CN1463267A Process for producing halogenated aromatic methyl amine
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1463178A Method to inhibit ethylene responses in plants
12/24/2003CN1462740A Method for preparing o-phenylendiamine and m-phenylene diamine by catalysis of mixed dinitro benzene and reduction with hydrogen being added
12/24/2003CN1462739A Preparing2,2' diamido bibenzil diphosphate by using method of liquid phase catalysis in low pressure with hydrogen being added
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667382 Straight chain aliphatic amine salt with primary, secondary and tertiary functionality; workability; emulsifying quick setting asphalt
12/23/2003US6667284 A coverings on a magnetic head for reading and writing on a computer disk drives, audio and video equipment; wear resistance; a compound select from hydrocarbyl-substituted cyclopentanes, cyclopentenes or cyclopentadienes
12/18/2003WO2003104194A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103609A2 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/18/2003WO2003038523A3 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
12/18/2003WO2002096804A3 Processes for the purification of higher diamondoids and compositions comprising such diamondoids
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232886 For resolving racemic mixtures; chemical intermediates, drugs
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2483141A1 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1370513A1 Malic acid addition salts of terbinafine
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1461746A Method for hydrogenating aromatic amine by ruthenium catalyst on carrier
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664224 Quaternary ammonium salt and process for the preparation thereof
12/11/2003WO2003102045A1 Hybrid polymer materials for liquid crystal alignment layers
12/11/2003WO2003101930A1 Method for producing 2-benzylaniline
12/11/2003WO2003101921A1 Method of synthesizing cf3-chf-cf2-nr2
12/11/2003WO2003101612A2 Catalyst for co and voc oxidation comprising alumina and ceria support
12/11/2003WO1999065855A3 Combinatorial libraries of geminally substituted amines
12/11/2003US20030229252 Process for producing 5-nitro-3,4-dihydro-1(2H)-naphthalinone, 1-5-naphthalenediamine and 1,5-naphthalene diisocyanate
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/10/2003EP1369412A1 Process for the preparation of 5-nitro-3,4-dihydro-1(2H)-naphthalenone, 1,5-naphthalendiamine and 1,5-naphthalendiisocyanate
12/10/2003EP1368351A2 7-(r)-amino-triazolopyrimidines, the production thereof and use of the same for combating phytopathogenic fungi
12/10/2003EP1368310A2 Improved methods of ortho alkylation
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1123270B1 Preparation of amines
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003CN1461291A Method for isomerisation of alcohols
12/10/2003CN1460683A Oxalibo purification
12/10/2003CN1460674A Method for preparing tetraalkylammonium hydroxide
12/10/2003CN1460673A Method for preparing 4-aminodiphenylamine
12/10/2003CN1130337C Process for synthesizing meta-aminophenylacetylene
12/10/2003CN1130336C Method for preparing meta-methyl benzene methanamine
12/10/2003CN1130324C Transferring hydrogenation process and catalyst
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099768A1 Method for reducing the content of an unsaturated amine in a mixture containing an amino nitrile, a diamine, a dinitrile or mixtures thereof
12/04/2003WO2003099720A1 Crystalline silicoaluminophosphate salt molecular sieve having octaoxygen-membered ring pore, process for producing the same and process for producing methylamine with the molecular sieve as catalyst
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/03/2003EP1366812A1 Process for hydrogenation of aromatic amines in presence of a supported ruthenium catalyst
12/03/2003EP1366020A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
12/03/2003EP1366004A2 Catalytic hydrogenation processes
12/03/2003EP1171415B1 Method of manufacturing alkylated diphenylamine compositions
12/03/2003CN1129575C Hydrogenation of unsaturated cyclic compounds
12/02/2003US6657085 By reacting nitro compounds with hydrazine at elevated temperature in the presence of an aqueous base; intermediates in the preparation of herbicides of the isobenzofuranone type
12/02/2003US6657084 Arylamine compound and organic electroluminescence device
12/02/2003US6656498 Cationic liposomes for gene transfer
11/2003
11/30/2003CA2430461A1 Process for hydrogenating an aromatic amine in the presence of a supported ruthenium catalyst
11/27/2003WO2003097580A1 Diimonium salt mixtures, aminium salts mixtures and use thereof
11/27/2003WO2003097571A1 Process for hydrogenating unactivated imines using ruthenium complexes as catalysts
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003096987A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003US20030220523 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003CA2486666A1 Diimonium salt mixtures, aminium salts mixtures and use thereof
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485586A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/26/2003EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
11/26/2003EP1082290B1 Process for the preparation of aceclofenac
11/26/2003CN1458921A Process for making N-aryl-anthranilic acid and their derivatives
11/26/2003CN1458919A Process for making hexamethylene diamine using ozone-treated adiponitrile that contains phosphorous compounds
11/26/2003CN1458141A Composite hole transport material
11/26/2003CN1458140A Process for preparing aniline and its derivatives
11/26/2003CN1128801C Triazolo (4,5-D) pyrimidine compounds
11/26/2003CN1128785C Method for producing optically active 1-phenyl ethylamines
11/26/2003CN1128784C Process for producing aromatic amines by gaseous phase hydrogenation
11/26/2003CN1128656C Method for extracting amine compounds from liquid medium
11/25/2003US6653507 Useful intermediate compound of pharmaceuticals for urinary incontinence
11/20/2003WO2003095585A1 Heat exchange fluids
11/20/2003WO2003095415A2 Aminated compounds bearing at least an allyl and a difluoromethyl and method used for synthesis thereof
11/20/2003WO2003095414A1 Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt
11/20/2003WO2003066572B1 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/20/2003WO2003042134A3 Process for the preparation of tertiary amines from primary amines and nitriles
11/20/2003WO2003037831A3 Method for preparing 4-nitroso-substituted aromatic amine
11/20/2003WO2003018532B1 Supported catalyst for nitrile hydrogenation
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216603 Fluorinated quaternary ammonium salt
11/19/2003EP1362026A2 Method for producing bis(trifluoromethyl)imido salts
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/18/2003US6649799 Method for producing primary and secondary amines by hydrogenation of nitriles and imines
11/18/2003US6649798 Reacting dried condensate of aniline and the methylene group-supplying agent in presence of solid, inorganic, acid catalysts to low-polymer methylenedianiline with a predominant 4,4'-isomer content